CAS 1242422-09-8 appears in our catalog under these names: SSTC3, 98%, SSTC3/ 98.65% (existing batch purity), SSTC3, 4-[N-Methyl-N-[4-(trifluoromethyl)phenyl]sulfamoyl]-N-[4-(pyridin-2-yl)thiazol-2-yl]benzamide, SSTC3, 99.37%. Offered by: AmBeed, TargetMol, GLPBio, Biosynth, Chemat. Available pack sizes: 100mg, 1mg, 10mg, 5mg, 50mg, 25mg, 10mM/1mL, 10 mg.
SSTC3 is a secondary carboxamide resulting from the formal condensation of the carboxy group of 4-{methyl[4-(trifluoromethyl)phenyl]sulfamoyl}benzoic acid with the amino group of 4-(pyridin-2-yl)-1,3-thiazol-2-amine. It is a casein kinase 1alpha activator (Kd = 32 nM) that inhibits WNT signaling (EC50 = 30 nM). It has a role as an antineoplastic agent and a Wnt signalling inhibitor. It is a secondary carboxamide, a member of benzamides, a member of pyridines, a sulfonamide, a member of 1,3-thiazoles and a member of (trifluoromethyl)benzenes.
Source: ChEBI
| Molecular formula | C23H17F3N4O3S2 |
|---|---|
| Molecular weight | 518.5 g/mol |
| IUPAC name | 4-[methyl-[4-(trifluoromethyl)phenyl]sulfamoyl]-N-(4-pyridin-2-yl-1,3-thiazol-2-yl)benzamide |
| InChIKey | HSFAATUFWDDUGW-UHFFFAOYSA-N |
| SMILES | CN(C1=CC=C(C=C1)C(F)(F)F)S(=O)(=O)C2=CC=C(C=C2)C(=O)NC3=NC(=CS3)C4=CC=CC=N4 |
Computed by PubChem (NCBI)